Table 1 Resistance patterns of two R. insidiosa isolates
From: Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa
Antibiotics | WCHRI065437(μg/mL) | WCHRI065162(μg/mL) |
|---|---|---|
Amikacin | 64(R) | 128(R) |
Amoxicillin/Clavulanate | 32(R) | 32(R) |
Ampicillin | 32(R) | 32(R) |
Aztreonam | 256(R) | 512(R) |
Cefepime | 2(S) | 16(I) |
Ceftazidime | 8(S) | 16(I) |
Ceftriaxone | 0.5(S) | 0.5(S) |
Ciprofloxacin | < 0.125(S) | < 0.125(S) |
Gentamicin | 32(R) | 16(R) |
Imipenem | 1(S) | 8(R) |
Levofloxacin | 0.125(S) | 0.25(S) |
Meropenem | 1(S) | 8(R) |
Nitrofurantoin | 512(R) | 512(R) |
Piperacillin/Tazobactam | < 4/4(S) | < 4/4(S) |
Polymyxin B | > 512(R) | > 512(R) |
Tigecycline | 0.5(S) | 1(S) |
Tobramycin | 32(R) | 32(R) |
Trimethoprim/Sulfamethoxazole | < 0.25/4.75(S) | < 0.25/4.75(S) |